Centers for Therapeutic Innovation

Pfizer, UCSF partner to expand drug discovery capabilities

Thursday, June 6, 2013

Pfizer has expanded its Centers for Therapeutic Innovation (CTI), which is dedicated to establishing partnerships with academic medical centers, into the development of small-molecule drug candidates through a partnership with the University of California, San Francisco (UCSF). This partnership provides investigators from UCSF with access to Pfizer’s small-molecule drug development capabilities, working with Pfizer scientists with the goal of jointly translating basic research into drug candidates to bring new therapies to patients.

[Read More]

Sanford-Burnham, Pfizer partner in drug discovery

Thursday, November 3, 2011

Sanford-Burnham Medical Research Institute is the latest research organization to partner with Pfizer as part of Pfizer’s commitment to transforming research and development through a focus on translational medicine. The Centers for Therapeutic Innovation (CTI) is a research unit at Pfizer dedicated to open innovation through establishing global partnerships with academic research institutions to bridge the gap between discovery science and clinical applications.

[Read More]